The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

In VIVID-1, 45.4% of mirikizumab-treated patients showed a response to treatment at 12 weeks and clinical remission defined as a score below 150 on the ... s IL-23 inhibitor Skyrizi (risankizumab ...

AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD) as the market for Humira biosimilars heats up.

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

“Ulcerative colitis can severely diminish a person’s quality of life and cause long-term health-related complications if it isn’t well managed,” said Professor Charlie Lees, Consultant ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...

Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD) as the market for ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

What does Nifty Midcap 150 represent? Comprises 150 mid-cap companies listed on the National Stock Exchange (NSE), offering exposure to medium-sized companies with growth potential, providing a ...

Purchasing Ford F-150 {Year} for sale online? Why not? It is predicted that the auto market will continue to be popular and become a popular consumption trend in the Philippines in 2025. Here are the ...